Gene · 442906
Papers1,644
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,644
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer. | Front Immunol | 2023 | 36993958 | PubTator, text mining | PubMed |
| The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases. | Pharmaceutics | 2023 | 36986865 | PubTator, text mining | PubMed |
| miRNA Dysregulation in Cardiovascular Diseases: Current Opinion and Future Perspectives. | Int J Mol Sci | 2023 | 36982265 | PubTator, text mining | PubMed |
| The Role of Exosomes in Pancreatic Ductal Adenocarcinoma Progression and Their Potential as Biomarkers. | Cancers (Basel) | 2023 | 36980662 | PubTator, text mining | PubMed |
| Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy. | Biomedicines | 2023 | 36979943 | PubTator, text mining | PubMed |
| Bioinformatics analysis of rheumatoid arthritis tissues identifies genes and potential drugs that are expressed specifically. | Sci Rep | 2023 | 36934132 | PubTator, text mining | PubMed |
| LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. | Genet Res (Camb) | 2023 | 36908851 | PubTator, text mining | PubMed |
| Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages. | Int J Mol Sci | 2023 | 36902304 | PubTator, text mining | PubMed |
| Potential of Circulating miRNAs as Molecular Markers in Mood Disorders and Associated Suicidal Behavior. | Int J Mol Sci | 2023 | 36902096 | PubTator, text mining | PubMed |
| Mitochondria Localized microRNAs: An Unexplored miRNA Niche in Alzheimer's Disease and Aging. | Cells | 2023 | 36899879 | PubTator, text mining | PubMed |
| CircRBM23 regulates the switch between osteogenesis and adipogenesis of mesenchymal stem cells via sponging miR-338-3p. | Clin Sci (Lond) | 2023 | 36896931 | PubTator, text mining | PubMed |
| Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential. | Front Genet | 2023 | 36896239 | PubTator, text mining | PubMed |
| CIRC_0012535 CONTRIBUTES TO LIPOPOLYSACCHARIDE-INDUCED FETAL LUNG FIBROBLAST APOPTOSIS AND INFLAMMATION TO REGULATE INFANTILE PNEUMONIA DEVELOPMENT BY MODULATING THE MIR-338-3P/IL6R SIGNALING. | Shock | 2023 | 36870073 | PubTator, text mining | PubMed |
| MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease. | Clin Kidney J | 2023 | 36865016 | PubTator, text mining | PubMed |
| miRNA Signature of Urine Extracellular Vesicles Shows the Involvement of Inflammatory and Apoptotic Processes in Diabetic Chronic Kidney Disease. | Pharm Res | 2023 | 36859746 | PubTator, text mining | PubMed |
| Coinfection of Dermal Fibroblasts by Human Cytomegalovirus and Human Herpesvirus 6 Can Boost the Expression of Fibrosis-Associated MicroRNAs. | Microorganisms | 2023 | 36838377 | PubTator, text mining | PubMed |
| Impact of the Voltage-Gated Calcium Channel Antagonist Nimodipine on the Development of Oligodendrocyte Precursor Cells. | Int J Mol Sci | 2023 | 36835129 | PubTator, text mining | PubMed |
| Tear Film MicroRNAs as Potential Biomarkers: A Review. | Int J Mol Sci | 2023 | 36835108 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. | Genes (Basel) | 2023 | 36833252 | PubTator, text mining | PubMed |
| MicroRNA-155-5p inhibition alleviates irritable bowel syndrome by increasing claudin-1 and ZO-1 expression. | Ann Transl Med | 2023 | 36819593 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442906/papers?page=7